4N8-58192-86927
3 vaccinations
3 coded responses
19 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 436 / OH
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-01-14
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-20
- 2021-01-29
-
2021-02-05
Survey response — day 21, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: Menstrual issues that are abnormal since the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — day 28, dose 2MedDRA: Intermenstrual bleeding — Feeling: FairFree text: Following the second Pfizer vaccine, I had abnormal spotting that was almost a second period in the middle of my cycleMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-24
- 2021-04-16
- 2021-07-14
-
2021-11-18
Dose 3 — Pfizer-BioNTech
- 2022-01-13
- 2022-05-19
-
2022-11-18
Survey response — 12 months, dose 3MedDRA: Ageusia, Anosmia, COVID-19, Cough, Diarrhoea, Headache, Myalgia, Nasal congestion, Respiratory tract congestion, SARS-CoV-2 test positive, Sinus congestion, Sneezing, Vomiting, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I contracted COVID-19. Symptoms developed on 11/2. I tested positive on 11/7. Symptoms included cough, congestion, wheezing, headache, muscle aches, vomiting and diarrhea, sneezing, nasal and sinus congestion, and loss of smell and taste.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — day 21, dose 2
Symptoms: Menstrual issues that are abnormal since the vaccine
Release 3 — day 28, dose 2
Symptoms: Following the second Pfizer vaccine, I had abnormal spotting that was almost a second period in the middle of my cycle
Release 12 — 12 months, dose 3
Symptoms: I contracted COVID-19. Symptoms developed on 11/2. I tested positive on 11/7. Symptoms included cough, congestion, wheezing, headache, muscle aches, vomiting and diarrhea, sneezing, nasal and sinus congestion, and loss of smell and taste.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Intermenstrual bleeding | ✓ | ✓ | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release